[HTML][HTML] Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
E Petra, J Siwy, A Vlahou, J Jankowski - PLoS One, 2022 - journals.plos.org
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …
Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease.
E Petra, J Siwy, A Vlahou, J Jankowski - PLoS ONE, 2022 - go.gale.com
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …
Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
E Petra, J Siwy, A Vlahou, J Jankowski - PLOS ONE, 2022 - ideas.repec.org
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …
[PDF][PDF] Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
E Petra, J Siwy, A Vlahou, J Jankowski - PLoS ONE, 2022 - researchgate.net
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …
Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
E Petra, J Siwy, A Vlahou, J Jankowski - PloS one, 2022 - pubmed.ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …
Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
E Petra, J Siwy, A Vlahou, J Jankowski - PLOS ONE, 2022 - econpapers.repec.org
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …
[HTML][HTML] Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
E Petra, J Siwy, A Vlahou, J Jankowski - PLOS ONE, 2022 - journals.plos.org
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …
Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease.
E Petra, J Siwy, A Vlahou, J Jankowski - Plos one, 2022 - europepmc.org
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …
[HTML][HTML] Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
E Petra, J Siwy, A Vlahou, J Jankowski - PLOS ONE, 2022 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …
Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
E Petra, J Siwy, A Vlahou, J Jankowski - PLOS ONE, 2022 - cris.maastrichtuniversity.nl
Chronic kidney disease (CKD) is characterized by the loss of kidney function. The molecular
mechanisms underlying the development and progression of CKD are still not fully …
mechanisms underlying the development and progression of CKD are still not fully …